GK PHARMA ApS: Financial statements 2024
CVR: 81267316
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
GK PHARMA ApS (CVR 81267316) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 3,822,556 and a net result of DKK 954,244 compared with DKK 861,844 the year before. That is an increase of 19% compared with the year before. Equity in the 2024 report amounted to DKK 2,232,152. The solvency ratio was 23.2%. The company had 18 employees in the financial year.
- Gross Profit
- DKK 3,822,556
- Profit/Loss
- DKK 954,244
- Equity
- DKK 2,232,152
- Total Assets
- DKK 9,614,882
- Employees
- 18
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 3.8 mio. | 954 t. | 2.2 mio. | 18 |
| 2023 | - | 3.2 mio. | 862 t. | 2.1 mio. | 15 |
| 2022 | - | 3.9 mio. | 1 mio. | 1.3 mio. | 16 |
| 2021 | 16.7 mio. | 4.8 mio. | 1.6 mio. | 1.8 mio. | - |
| 2020 | 14 mio. | 4.6 mio. | 1.4 mio. | 1.6 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
GK PHARMA ApS has published its annual report for 2023. Gross profit came to DKK 3,213,556, and the net result was DKK 861,844.
About GK PHARMA ApS
GK PHARMA ApS is a Danish company of the type Anpartsselskab based in Køge, founded in 1977. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The company was previously named DUNCANS, ERIK V. THOMSEN ApS and ERIK V. THOMSEN ApS. The management consists of Klaus Groth. The board consists of Dorthe Groth (chair) and Klaus Groth. The company is owned by Salvefabrikken ApS. The company has 17 employees (2026). In 2025, the company reported a gross profit of DKK 5,931,212 and a net result of DKK 2,646,889 compared with DKK 954,244 the year before. Equity in the 2025 report amounted to DKK 4,029,041.